Last reviewed · How we verify
brimonidine 0.1%
brimonidine 0.1% is a Small molecule drug developed by Augenarztpraxis Breisach. It is currently FDA-approved.
Brimonidine 0.1% is a small molecule used to treat conditions such as glaucoma, ocular hypertension, and normal tension glaucoma. It is used as an intervention in clinical trials to control intraocular pressure.
At a glance
| Generic name | brimonidine 0.1% |
|---|---|
| Sponsor | Augenarztpraxis Breisach |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Upneeq vs. Lumify Ptosis (PHASE4)
- Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost (PHASE4)
- The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients (PHASE4)
- Superior vs Temporal Laser Peripheral Iridotomy in Primary Angle Closure Suspects (PACS) (NA)
- Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2% (PHASE2)
- Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy (PHASE4)
- Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves (PHASE4)
- A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- brimonidine 0.1% CI brief — competitive landscape report
- brimonidine 0.1% updates RSS · CI watch RSS
- Augenarztpraxis Breisach portfolio CI
Frequently asked questions about brimonidine 0.1%
What is brimonidine 0.1%?
Who makes brimonidine 0.1%?
What development phase is brimonidine 0.1% in?
Related
- Manufacturer: Augenarztpraxis Breisach — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing